UCB has announced positive new three-year data for its inflammatory disease drug Bimzelx (bimekizumab) in adults with active ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic ...

NewAmsterdam Pharma has shared promising Alzheimer’s disease (AD) biomarker data from a late-stage study of its ...

Today, by contrast, the marketers I study complain of being swamped by data and confused by information overload. And when I ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

By combining different treatment options – especially those involving immuno-oncology (IO) – researchers aim to develop ...

As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and ...

The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of ...

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the ...

The authorisation comes three months after the MHRA approved Johnson & Johnson’s Lazcluze (lazertinib), which is also ...